Breast Augmentation denials in California external review

In the California DMHC record, independent physician reviewers decided 23 published external-review cases involving Breast Augmentationand overturned the plan’s denial in 56.5%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
23
2003–2025
Overturned
56.5%
13 denials reversed

By condition

Published outcomes when Breast Augmentation was denied for these conditions.
ConditionDecisionsOverturned
Gender Dysphoria18
72.2%
Typical time to a decision
21 days
Most land between 13 and 22 days

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested surgical breast augmentation for treatment of her gender dysphoria. The physician reviewer found that the patient presents with gender dysphoria which is a source of significant adverse effect on her mental health. She has been transitioning from the male-to-female gender over the past four to five years. She has been treated with hormonal therapy without adequate breast development. The patient is well-documented to have gender dysphoria. Currently, her examination and photographs depict a lack of breast development and is more consistent with male anatomy. The surgical concept of breast augmentation in male-to-female transgender patients is well-established and documented within the community of plastic surgeons.
Medical Necessity · 2015 · IMR MN15-20866
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for breast augmentation.For many transgender female patients, hormones alone do not adequately change breast appearance to address gender dysphoria. One study noted that “Although transwomen typically initiate hormonal therapy before surgical evaluation, there is a wide response range to estrogen therapy. Ultimately, the majority of individuals choose to pursue surgical intervention, with breast augmentation rates reported up to 67% in the transwomen population.” The authors noted further that “studies support breast augmentation as a quality-of-life operation and not simply a cosmetic procedure.” Similarly, The World Professional Association for Transgender Health, Inc.
Medical Necessity · 2025 · IMR MN25-44999

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: A transgender enrollee has requested authorization and coverage for breast augmentation for treatment of the enrollee’s gender dysphoria. Findings: The physician reviewer found that The documentation provided does not support the medical necessity for the requested services in this clinical setting. The medical necessity of breast augmentation for transgender females with gender dysphoria is a case specific determination. This patient has documented gender dysphoria and has been undergoing female transitioning with hormonal therapy for approximately four years. Based on her diagnosis and history, her external anatomy should be more consistent with the female gender. However, her examination detail and review of the photographs support that she has had sufficient breast development with hormone therapy.
Medical Necessity · 2018 · IMR MN18-27590
Nature of Statutory Criteria/Case Summary:An enrollee has requested breast augmentation for treatment of the enrollee’s gender dysphoria. The submitted documentation does not support the medical necessity for the requested services in this clinical setting. The patient has been assessed with gender dysphoria. The medical necessity of breast augmentation for transgender females with gender dysphoria is a case specific determination. The surgical concept of breast augmentation in individuals transitioning from the male-to-female gender is well-established and documented within the community of plastic surgeons. However, in this patient’s case, her examination and photographs depict breast development more consistent with a female than a male. The patient has been treated with hormone therapy and the submitted photographs document the presence of visible breast tissue.
Medical Necessity · 2016 · IMR MN16-23826

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Breast Augmentation, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Breast Augmentation? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39